Clinical Trials Browser

Phase 3 × INDUSTRY × ixabepilone × Clear all

NCT02915744 2023-04-14

ATTAIN

Phase 3 Completed

178 enrolled 37 charts

Breast Neoplasms, Carcinoma, Neoplasm Metastasis

NCT00080301 2020-11-02

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Phase 3 Completed

752 enrolled 22 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00082433 2020-11-02

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Phase 3 Completed

1,221 enrolled 18 charts

Breast Neoplasms, Neoplasms

NCT00883116 2017-03-09

IXAMPLE2

Phase 3 Terminated

551 enrolled 13 charts

Endometrial Neoplasms